FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 4.0.1  |  FHIR Version n/a  User: [n/a]

423259008: panitumumab (substance)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2007. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
11091000188114 Panitumumab fr Synonym (core metadata concept) Inactive Entire term case sensitive (core metadata concept) SNOMED CT Common French translation module (core metadata concept)
193231000077117 panitumumab fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Common French translation module (core metadata concept)
2639908017 Panitumumab (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
2643940012 Panitumumab en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
469921000077112 panitumumab (substance) fr Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT Common French translation module (core metadata concept)

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
panitumumab est un(e) (attribut) protéine inhibitrice d’une enzyme true Inferred relationship Some
panitumumab est un(e) (attribut) substance avec mécanisme d'action inhibiteur du récepteur du facteur de croissance épidermique (substance) true Inferred relationship Some
panitumumab est un(e) (attribut) Monoclonal antibody (substance) true Inferred relationship Some
panitumumab est un(e) (attribut) Monoclonal antibody agent (substance) false Inferred relationship Some
panitumumab est un(e) (attribut) produit chimique catégorisé selon sa fonction false Inferred relationship Some
panitumumab Has disposition (attribute) Epidermal growth factor receptor inhibitor true Inferred relationship Some
Inbound Relationships Type Active Source Characteristic Refinability Group
Panitumumab-containing product in parenteral dose form a pour principe actif (attribut) True panitumumab Inferred relationship Some 1
Product containing only panitumumab (medicinal product) a pour principe actif (attribut) True panitumumab Inferred relationship Some 1
Panitumumab only product in parenteral dose form a pour principe actif (attribut) True panitumumab Inferred relationship Some 1
Product containing precisely panitumumab 20 milligram/1 milliliter conventional release solution for injection (clinical drug) Has basis of strength substance (attribute) True panitumumab Inferred relationship Some 1
Product containing precisely panitumumab 20 milligram/1 milliliter conventional release solution for injection (clinical drug) Has precise active ingredient True panitumumab Inferred relationship Some 1
Product containing panitumumab (medicinal product) a pour principe actif (attribut) True panitumumab Inferred relationship Some 1
Panitumumab 20mg/mL injection solution 5mL vial (product) a pour principe actif (attribut) False panitumumab Inferred relationship Some
Panitumumab 100 mg/5 mL solution for injection vial Has basis of strength substance (attribute) False panitumumab Inferred relationship Some 1
Panitumumab 100 mg/5 mL solution for injection vial Has precise active ingredient False panitumumab Inferred relationship Some 1

This concept is not in any reference sets

Back to Start